investorscraft@gmail.com

Intrinsic ValueColgate-Palmolive Company (0P59.L)

Previous Close£88.37
Intrinsic Value
Upside potential
Previous Close
£88.37

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Colgate-Palmolive operates as a global leader in the consumer goods sector, specializing in oral care, personal care, home care, and pet nutrition. The company generates revenue through a diversified portfolio of well-established brands such as Colgate, Palmolive, Hill's Science Diet, and Tom's of Maine, sold via traditional retail, eCommerce, and professional channels. Its Oral, Personal and Home Care segment dominates revenue, leveraging strong brand equity and distribution networks across emerging and developed markets. The Pet Nutrition segment, though smaller, holds a premium position in veterinary-recommended pet food, supported by scientific formulations. Colgate-Palmolive maintains a defensive market position due to the essential nature of its products, which exhibit consistent demand even during economic downturns. Its global footprint, with significant exposure to high-growth regions, provides resilience against regional volatility. The company invests heavily in R&D and marketing to sustain brand loyalty and innovation, particularly in sustainability-focused product lines. Competitive advantages include scale efficiencies, retailer relationships, and a focus on premiumization in oral and pet care, though it faces pressure from private-label competitors and shifting consumer preferences toward natural ingredients.

Revenue Profitability And Efficiency

Colgate-Palmolive reported $20.1 billion in revenue for the period, with net income of $2.89 billion, reflecting a robust 14.4% net margin. Operating cash flow stood at $4.11 billion, underscoring efficient working capital management. Capital expenditures of $561 million indicate disciplined reinvestment, with free cash flow supporting dividends and debt reduction. The company’s profitability metrics align with industry leaders, though margin expansion faces headwinds from input cost inflation.

Earnings Power And Capital Efficiency

Diluted EPS of $3.51 demonstrates stable earnings power, driven by pricing actions and cost optimization. The company’s capital-light model, with low beta (0.39), highlights defensive earnings quality. Return metrics are supported by high inventory turnover and brand-driven pricing power, though pet nutrition’s growth requires incremental R&D and marketing spend.

Balance Sheet And Financial Health

Colgate-Palmolive maintains a solid balance sheet with $1.1 billion in cash and $8.51 billion in total debt, reflecting a manageable leverage profile. Debt-to-EBITDA ratios are within investment-grade parameters, and liquidity is sufficient to cover near-term obligations. The company’s conservative financial policy prioritizes dividend stability and gradual deleveraging.

Growth Trends And Dividend Policy

Organic growth is driven by pricing and emerging market penetration, with pet nutrition as a long-term driver. The $2.02 annual dividend per share, yielding ~2.3%, underscores a commitment to shareholder returns, supported by 60+ years of consecutive dividend increases. Share buybacks are minimal, reflecting a focus on reinvestment and dividend sustainability.

Valuation And Market Expectations

At a $74.8 billion market cap, Colgate-Palmolive trades at a premium to peers, reflecting its defensive positioning and consistent cash flows. Investors price in mid-single-digit revenue growth and margin stability, with valuation multiples implying low volatility expectations. The stock’s low beta aligns with its status as a bond proxy in consumer staples.

Strategic Advantages And Outlook

Colgate-Palmolive’s strengths lie in its global brand equity, diversified revenue streams, and resilient demand. Near-term challenges include commodity cost pressures and competitive intensity in oral care. Long-term opportunities include premiumization in pet nutrition and sustainability-driven innovation. The company’s outlook remains stable, with disciplined capital allocation supporting steady growth and shareholder returns.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount